Extensively drug-resistant (XDR) Pseudomonas aeruginosa identified in Lima, Peru co-expressing a VIM-2 metallo-β-lactamase, OXA-1 β-lactamase and GES-1 extended-spectrum β-lactamase-Reference-Cited by-同舟云学术

Extensively drug-resistant (XDR) Pseudomonas aeruginosa identified in Lima, Peru co-expressing a VIM-2 metallo-β-lactamase, OXA-1 β-lactamase and GES-1 extended-spectrum β-lactamase

Published:2018-07-01 Issue:7 Volume:5 Page:
ISSN:2053-3721
Container-title:JMM Case Reports
language:en
Short-container-title:

Author:

Ríos Paul¹,Rocha Claudio¹,Castro William²,Vidal Maria²,Canal Enrique¹,Bernal Manuela¹,Reynolds Nathanael D.¹,Tilley Drake H.³,Simons Mark P.¹

Affiliation:

1. 1U.S. Naval Medical Research Unit No.6 (NAMRU-6), Lima, Perú

2. 2Centro Médico Naval “Cirujano Mayor Santiago Távara (CEMENA)”, Lima, Perú

3. 3Naval Medical Center, San Diego, USA

Publisher

Microbiology Society

Subject

Microbiology (medical),Microbiology

Reference22 articles.

1. Time-to-positivity of blood culture: An independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia

2. Pseudomonas aeruginosaBacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome

3. Epidemiology and Characteristics of Metallo-β-Lactamase-ProducingPseudomonas aeruginosa

4. Metallo-β-lactamases: a last frontier for β-lactams?

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extensively drug-resistant Pseudomonas aeruginosa: clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal – A cross-sectional and retrospective observational study;Frontiers in Microbiology;2024-02-13

2. Health economics matters in the nanomaterial world: Cost-effectiveness of utilizing an inhalable antibacterial nanomaterial for the treatment of multidrug-resistant pneumonia;Technology in Society;2021-08

3. Mobile Carbapenemase Genes in Pseudomonas aeruginosa;Frontiers in Microbiology;2021-02-18

4. First report of bla GES-1 in Proteus mirabilis clinical isolates;Revista da Sociedade Brasileira de Medicina Tropical;2021

5. Update on the epidemiology of carbapenemases in Latin America and the Caribbean;Expert Review of Anti-infective Therapy;2020-09-11